These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6116102)

  • 1. Partial preservation of pancreatic beta-cell function in children with diabetes.
    Elliott RB; Crossley JR; Berryman CC; James AG
    Lancet; 1981 Sep; 2(8247):631-2. PubMed ID: 6116102
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual pancreatic beta-cell function in insulin-dependent diabetes mellitus.
    Amemiya S; Higashida K; Fujimoto M; Asayama K; Ichimura K; Kusano S; Ohyama K; Kato K
    Acta Paediatr Jpn; 1987 Jun; 29(3):408-13. PubMed ID: 3144870
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors influencing residual pancreatic beta cell function in recently diagnosed Type 1 diabetic children.
    Hill MA; Court JM
    Aust Paediatr J; 1982 Mar; 18(1):37-9. PubMed ID: 7049145
    [No Abstract]   [Full Text] [Related]  

  • 4. [Function of the islands of Langerhans and the course of diabetes mellitus in children].
    Kniazev IuA; Vakhrusheva LL; Demidova LV; Kuznetsova NN
    Pediatriia; 1981 Oct; (10):10-2. PubMed ID: 7031587
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial preservation of pancreatic beta-cell function in children with diabetes.
    Elliott RB; Crossley JR; Berryman CC; James AG
    Lancet; 1981 Jul; 2(8236):1-4. PubMed ID: 6113394
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic beta cells in insulin-dependent diabetes.
    Pipeleers D; Ling Z
    Diabetes Metab Rev; 1992 Oct; 8(3):209-27. PubMed ID: 1292912
    [No Abstract]   [Full Text] [Related]  

  • 7. Free radicals as mediators of pancreatic islet beta-cell injury in autoimmune diabetes.
    Rabinovitch A
    J Lab Clin Med; 1992 May; 119(5):455-6. PubMed ID: 1583400
    [No Abstract]   [Full Text] [Related]  

  • 8. Does partial preservation of residual beta-cell function justify immune intervention in recent onset Type I diabetes?
    Kolb H; Gale EA
    Diabetologia; 2001 Oct; 44(10):1349-53. PubMed ID: 11692186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function of pancreatic islets isolated from a type 1 diabetic patient.
    Marchetti P; Dotta F; Ling Z; Lupi R; Del Guerra S; Santangelo C; Realacci M; Marselli L; Di Mario U; Navalesi R
    Diabetes Care; 2000 May; 23(5):701-3. PubMed ID: 10834434
    [No Abstract]   [Full Text] [Related]  

  • 10. [State of the islet apparatus in children depending on the duration of diabetes mellitus].
    Vakhrusheva LL; Golovanova VB; Demidova LV; Smazhnova NA
    Pediatriia; 1980 Jun; (6):32-4. PubMed ID: 6995927
    [No Abstract]   [Full Text] [Related]  

  • 11. [Functional study of the endocrine pancreas in healthy people with a family history of insulin-dependent diabetes mellitus].
    Miralles García JM; Reglero Chillón A; Corrales Hernández JJ; García Díez LC; Mories Alvarez MT; de Castro del Pozo S
    Med Clin (Barc); 1987 Mar; 88(12):494-6. PubMed ID: 3295408
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of influence of residual beta-cell function on the glucagon and pancreatic polypeptide secretion in type I (insulin-dependent) diabetic patients.
    Tronier B; Madsbad S; Krarup T; Faber OK
    Diabete Metab; 1987 Apr; 13(2):141-3. PubMed ID: 3297833
    [No Abstract]   [Full Text] [Related]  

  • 13. Exocrine pancreatic function in diabetes mellitus.
    Gröger G; Layer P
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):740-6. PubMed ID: 7496861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin secretion, glucose tolerance test and various indicators of lipid metabolism in children with hereditary diabetes mellitus].
    Sherbacheva LN; Lobanova AM; Volkova TD
    Pediatriia; 1981 Oct; (10):19-21. PubMed ID: 7031588
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for Residual and Partly Reparable Insulin Secretory Function and Maintained β-Cell Gene Expression in Islets From Patients With Type 1 Diabetes.
    Satin LS; Schnell S
    Diabetes; 2015 Jul; 64(7):2335-7. PubMed ID: 26106195
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta cell function in the preclinical period of insulin-dependent diabetes.
    McCulloch DK; Palmer JP; Benson EA
    Diabetes Metab Rev; 1987 Jan; 3(1):27-43. PubMed ID: 3552524
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of residual functional beta-cell response in childhood and juvenile diabetes in relation to early diagnosis and to the forms of onset of the disease].
    Campea L; Raponi MP; Trotta MR; Costantino F; Davi G; Orsini M
    Recenti Prog Med; 1983 Jan; 74(1):36-52. PubMed ID: 6346417
    [No Abstract]   [Full Text] [Related]  

  • 18. The variable but inevitable loss of beta cells in overt type 1 diabetes.
    Rosenbloom AL
    Pediatr Diabetes; 2003 Mar; 4(1):1-3. PubMed ID: 14655516
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heterogeneity of pancreatic pathology in insulin-dependent diabetes].
    Gepts W; In 't Veld P
    Journ Annu Diabetol Hotel Dieu; 1984; ():13-20. PubMed ID: 6399529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.